The laboratory studies RNA interference therapy for cancers and infectious diseases such as Influenza, Respiratory syncytial virus and Hendravirus. We are particularly interested in nanoparticle delivery systems and the interface between RNAi and the immune system. We take a multidisciplinary approach to our research work and we have a diverse set of national and international collaborators in the areas of nanoparticle system development, immunology and cancer biology.
Professor Nigel McMillan.
Director, Molecular Basis of Disease Program, Griffith Health Institute
Deputy Head of School (Research), School of Medical Sciences
Griffith University, Gold Coast Campus
Southport 4222 QLD, Australia
Ph +61 7 5552 7135
Adjunct Associate Professor, Diamantina Institute
University of Queensland
BSc Hons (UWA), Grad Dip Ed, PhD (UWA) Future Research Leader/ARC Research Fellow (DECRA), Institute for Glycomics, Griffith University
Phone: (07) 5552 7858
My research centers on infectious diseases, in particular understanding how pathogens are transmitted and cause disease, with the goal of developing new therapeutics to target various aspects of the infectious process. Currently I am at the Institute for Glycomics at Griffith University where I am examining the pathology and glycobiology of infection with emerging mosquito-borne viruses such as chikungunya virus (CHIKV), dengue virus and Ross River virus (RRV). The ultimate goal being to limit virus dissemination within the mosquito host and prevent disease transmission and spread.
I am currently looking for PhD students to join my team.
Institute for Glycomics (G26)
Griffith University (Gold Coast Campus)